Beck Bode LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-56,017
Closed -$13.2M 105
2024
Q4
$13.2M Buy
+56,017
New +$13.2M 2.41% 24